Cargando…

Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors

Engineering potent bispecific antibodies from single-chain variable fragments (scFv) remains difficult due to the inherent instability and insufficient binding of scFv's compared to their parental immunoglobulin format. Previously, we described a scFv-based bispecific antibody (scBA) against di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Ming, Santich, Brian H., Xu, Hong, Ahmed, Mahiuddin, Huse, Morgan, Cheung, Nai-Kong V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938304/ https://www.ncbi.nlm.nih.gov/pubmed/27471647 http://dx.doi.org/10.1080/2162402X.2016.1168557

Ejemplares similares

Structure Based Refinement of a Humanized Monoclonal Antibody That Targets Tumor Antigen Disialoganglioside GD2
por: Ahmed, Mahiuddin, et al.
Publicado: (2014)

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)

Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library
por: Shams, Nasir, et al.
Publicado: (2022)

Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2
por: Hoseini, Sayed Shahabuddin, et al.
Publicado: (2017)

Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies
por: V. Kholodenko, Irina, et al.
Publicado: (2019)

Characterization and analysis of scFv-IgG bispecific antibody size variants
por: Cao, Mingyan, et al.
Publicado: (2018)

Cloning approach and functional analysis of anti-intimin single-chain variable fragment (scFv)
por: Menezes, Márcio A, et al.
Publicado: (2011)

Expression of Single Chain Variable Fragment (scFv) Molecules in Plants: A Comprehensive Update
por: Satheeshkumar, Padikara Kutty
Publicado: (2020)

The Four-State Equilibrium Unfolding of a scFv Antibody Fragment
por: Pedroso, Idolka, et al.
Publicado: (2002)

Relative Contribution of Framework and CDR Regions in Antibody Variable Domains to Multimerisation of Fv- and scFv-Containing Bispecific Antibodies
por: Bhatta, Pallavi, et al.
Publicado: (2018)

High-Throughput Generation of Bipod (Fab × scFv) Bispecific Antibodies Exploits Differential Chain Expression and Affinity Capture
por: Nesspor, Thomas C., et al.
Publicado: (2020)

Construction and Periplasmic Expression of a Bispecific Tandem scFv for Dual Targeting of Immune Checkpoints
por: Rashti, Amirreza, et al.
Publicado: (2023)

Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells
por: Kalinovsky, Daniel V., et al.
Publicado: (2023)

Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
por: Rodríguez-Nava, Cynthia, et al.
Publicado: (2023)

“Stapling” scFv for multispecific biotherapeutics of superior properties
por: Boucher, Lauren E., et al.
Publicado: (2023)

scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012)

Generation of a Single Chain Antibody Variable Fragment (scFv) to Sense Selectively RhoB Activation
por: Chinestra, Patrick, et al.
Publicado: (2014)

Refolded scFv Antibody Fragment against Myoglobin Shows Rapid Reaction Kinetics
por: Song, Hyung-Nam, et al.
Publicado: (2014)

Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments
por: Stech, Marlitt, et al.
Publicado: (2014)

P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma
por: Shi, Zhiyuan, et al.
Publicado: (2022)

Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4
por: Kalinovsky, Daniel V., et al.
Publicado: (2023)

Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)

Production of cross neutralizing single chain fragment variables (scFv) from HIV-1 infected Indian children
por: Kumar, Sanjeev, et al.
Publicado: (2014)

Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments
por: Nannini, Francesco, et al.
Publicado: (2020)

Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity
por: Pelat, Thibaut, et al.
Publicado: (2009)

Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
por: Girgis, Mark D, et al.
Publicado: (2011)

In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe
por: Mazzocco, Claire, et al.
Publicado: (2016)

Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains
por: Lakowitz, Antonia, et al.
Publicado: (2017)

Generation and characterization of a human single-chain fragment variable (scFv) antibody against cytosine deaminase from Yeast
por: Mallano, Alessandra, et al.
Publicado: (2008)

Expression, production, and renaturation of a functional single-chain variable antibody fragment (scFv) against human ICAM-1
por: Sun, H., et al.
Publicado: (2014)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Humanization and directed evolution of the selenium-containing scFv phage abzyme
por: Xu, Yan, et al.
Publicado: (2018)

Baculovirus display of single chain antibody (scFv) using a novel signal peptide
por: Kitidee, Kuntida, et al.
Publicado: (2010)

Backbone and side-chain resonance assignments of the NISTmAb-scFv and antigen-binding study
por: Ghasriani, Houman, et al.
Publicado: (2022)

Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo
por: Rülker, Torsten, et al.
Publicado: (2012)

Inhibition of Francisella tularensis phagocytosis using a novel anti-LPS scFv antibody fragment
por: Mechaly, Adva, et al.
Publicado: (2019)

Generation and immune-characterization of single chain fragment variable (scFv) antibody recognize breast cancer cells line (MCF-7)
por: Mahgoub, Ilham, et al.
Publicado: (2014)

Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes
por: Tanaka, Kazuki, et al.
Publicado: (2017)

Isolation of Polyclonal Single-Chain Fragment Variable (scFv) Antibodies Against Venomous Snakes of Iran and Evaluation of Their Capability in Neutralizing the Venom
por: Kadkhodazadeh, Maryam, et al.
Publicado: (2020)

Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
por: Santich, Brian H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oupak32k17hae8l21hfivovb95